Coverage of several self-administered DMARDs declined across Medicare Part D plans between 2022 and 2026, with differential coverage noted across plan types.

Reference fabrication has increased among published medical research papers, with the rate of fabrication growing from 2025 to 2026.

Telemedicine adoption was not associated with changes in visit numbers or medical spending among insured adults.

A targeted birth-dose vaccine recommendation for hepatitis B virus in the United States would likely increase neonatal infections.

Aluminum-adjuvanted vaccines showed no association with long-term health outcomes, including asthma and autism spectrum disorder.

While all patients with mycosis fungoides experience improvements with NB-UVB phototherapy, patients with FST I to III had ...

HIV pre-exposure prophylaxis (PrEP) uptake remains suboptimal among adolescents and young adults in the United States, ...

Primary care visit rates and access decreased among Medicare beneficiaries from 2017 to 2023 in the United States.

Bimekizumab is associated with significant complete clearance rates at 4 years among patients with scalp, nail, or palmoplantar psoriasis.

The EULAR released a 2025 update to the 2018 recommendations for physical activity among individuals with IA or OA, with an emphasis on reducing sedentary behavior.

An acne management guideline was updated, which includes new considerations for isotretinoin, hormonal therapies, new topical ...

Pediatric patients with Down syndrome have a greater prevalence of overall and specific nail disorders than control patients.